Document is current

Article History

Received: 19 July 2023

Accepted: 24 October 2023

First Online: 3 November 2023

Declarations

:

: M.H. conflict of interest with Merck Serono (advisory role,speakers’ bureau, honoraria, travel expenses, research funding); MSD (advisory role, speakers’ bureau, honoraria, travel expenses, research funding); AstraZeneca (research funding, advisory role, speakers’ bureau, honoraria, travel expenses); Novartis (research funding); BMS (advisory role, honoraria, speakers’ bureau); Teva (travel expenses). M.E. declares: Personal fees, travel costs and speaker’s honoraria from MSD, AstraZeneca, Janssen-Cilag, Cepheid, Roche, Astellas, Diaceutics; research funding from AstraZeneca, Janssen-Cilag, STRATIFYER, Cepheid, Roche, Gilead; advisory roles for Diaceutics, MSD, AstraZeneca, Janssen-Cilag, GenomicHealth. The other authors (M.D., A.O.G., R.F., H.I., A.H., and A.M.K.) do not declare any conflicts of interest with respect to this study.